UNSPSC 51241128: Hypromellose

This classification denotes a synthetic polymer, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3NXW29V3WO. European Medicines Agency schedules Hypromellose in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02622MIG. Hypromellose generally arises in the molecular formula (C9H14O6)N.CH3.H. The term 'hypromellose' is a European Pharmacopoeia designation. SMILES: CC(COCC1C(C(C(C(O1)OC)OCC(C)O)OCC(C)O)OC2C(C(C(C(O2)COC)OC3C(C(C(C(O3)CO)OC)O)O)OC)OC)O.

UNSPSC 51241128 Hypromellose, a Commodity code, addresses the procurement of hypromellose—a cellulose ether pharmaceutical excipient used in tablet binders, film coatings, and ophthalmic solutions—by state and local health departments, correctional facilities, state universities with pharmacy or medical programs, and public hospital systems. The code captures purchases of this ingredient in bulk pharmaceutical manufacturing and compounding operations where state and local agencies either produce medications in-house or procure pre-formulated products containing hypromellose as a specified component. Recent state and local solicitations under this code show limited activity; the available opportunity records do not identify specific recent RFPs, RFQs, or ITBs for hypromellose procurement at the state or local level.

Geographic activity remains sparse across the available recent-opportunities data, with no identified state or jurisdiction showing concentrated procurement volume under this Commodity code. The lack of recent posted opportunities reflects both the specialized nature of hypromellose procurement—most state and local agencies source it through pharmaceutical wholesalers or as a component within finished-goods purchases rather than as a standalone ingredient—and the episodic nature of bulk pharmaceutical-excipient contracts. Firms pursuing work under this code should monitor state health department RFPs for pharmaceutical manufacturing or compounding services, correctional-system medication-procurement solicitations, and public-hospital pharmacy supply contracts where hypromellose specifications appear, as these vehicles are more likely to surface demand than direct commodity requests.